Compounds > cremophor el
Page last updated: 2024-08-24

cremophor el and Leukemia

cremophor el has been researched along with Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, CH; Aszalos, A; Hrycyna, CA; Hwang, M; Licht, T; Pine, PS; Yin, JJ1
Canada, AL; Ross, HJ; Slater, LM1
Chuang, LF; Chuang, RY; Israel, M; Zhao, FK1

Other Studies

3 other study(ies) available for cremophor el and Leukemia

ArticleYear
Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells.
    International journal of cancer, 1996, Jan-26, Volume: 65, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Division; Cell Membrane; Cyclosporins; Glycerol; Humans; Leukemia; Transfection; Tumor Cells, Cultured; Verapamil

1996
Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cyclosporine; Cytokines; Disease Models, Animal; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Glycerol; Growth Substances; Humans; Immunosuppressive Agents; Leukemia; Mice; Paclitaxel; Respiratory Tract Neoplasms; Survival Rate; Treatment Outcome; Tumor Cells, Cultured

1997
Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C.
    Biochemical and biophysical research communications, 1989, Mar-31, Volume: 159, Issue:3

    Topics: Binding, Competitive; Cell Line; DNA Polymerase II; Drug Carriers; Glycerol; Humans; Kinetics; Leukemia; Phorbol 12,13-Dibutyrate; Protein Binding; Protein Kinase C; Protein Kinases; RNA Polymerase II; Solvents; Tetradecanoylphorbol Acetate

1989